Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LABORATORIET I NANNASGADE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.0% 2.0%   Bankruptcy risk   4.1% 3.5% 4.3% 2.9% 6.2% 4.5% 17.2% 17.2%   Credit score (0-100)   50 55 48 56 37 46 9 9   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   662 579 707 651 1,448 1,831 0.0 0.0   EBITDA   154 122 207 18.3 -392 16.4 0.0 0.0   EBIT   143 119 190 18.3 -537 -129 0.0 0.0   Pre-tax profit (PTP)   109.5 91.8 173.7 5.7 -542.8 -130.1 0.0 0.0   Net earnings   78.4 69.3 134.1 2.8 -423.0 -100.5 0.0 0.0   Pre-tax profit without non-rec. items   110 91.8 170 5.7 -543 -130 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   20.2 17.5 0.0 1,450 1,305 1,160 0.0 0.0   Shareholders equity total   121 190 324 128 -295 -396 -521 -521   Interest-bearing liabilities   346 274 46.5 2,132 2,176 2,487 521 521   Balance sheet total (assets)   762 706 724 2,471 2,330 2,651 0.0 0.0   Net Debt   -249 -240 -589 1,519 1,673 1,796 521 521     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   662 579 707 651 1,448 1,831 0.0 0.0   Gross profit growth   31.9% -12.5% 22.1% -8.0% 122.4% 26.5% -100.0% 0.0%   Employees   1 2 2 1 4 5 0 0   Employee growth %   0.0% 100.0% 0.0% -50.0% 300.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   762 706 724 2,471 2,330 2,651 0 0   Balance sheet change%   17.6% -7.2% 2.4% 241.5% -5.7% 13.8% -100.0% 0.0%   Added value   154.3 122.1 207.5 18.3 -537.0 16.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -23 -5 -35 1,450 -290 -290 -1,160 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.5% 20.6% 26.9% 2.8% -37.1% -7.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.3% 16.7% 26.6% 1.2% -21.1% -4.5% 0.0% 0.0%   ROI %   30.4% 26.3% 43.7% 1.4% -23.6% -5.3% 0.0% 0.0%   ROE %   96.0% 44.6% 52.1% 1.2% -34.4% -4.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   15.9% 26.9% 44.8% 5.2% -11.2% -13.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -161.4% -196.9% -283.8% 8,295.7% -426.6% 10,926.6% 0.0% 0.0%   Gearing %   286.5% 144.3% 14.3% 1,665.3% -737.7% -628.7% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.6% 9.9% 12.7% 1.2% 0.3% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 1.8 1.8 6.1 2.1 2.3 0.0 0.0   Current Ratio   1.6 2.1 2.0 6.2 2.7 3.3 0.0 0.0   Cash and cash equivalent   595.4 514.9 635.4 613.4 503.7 690.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   274.0 358.3 358.6 855.7 648.0 1,040.7 -260.3 -260.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   154 61 104 18 -134 3 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   154 61 104 18 -98 3 0 0   EBIT / employee   143 60 95 18 -134 -26 0 0   Net earnings / employee   78 35 67 3 -106 -20 0 0